Assignee
ASKA PHARM CO LTD
JP·21 granted patents·9 pending applications·18 citations·filing 2002–2025
Top patents by PatentIndex Score
30 records- 0184US10710967B2Pyrimidine derivativeASKA PHARM CO LTD·Filed 2016·Granted Jul 14, 2020·3 cites·13 claims
- 0279US11208431B2Stable isotope-labeled compoundsASKA PHARM CO LTD·Filed 2018·Granted Dec 28, 2021·1 cites·9 claims
- 0376US7799775B2Pyrimidine derivativesASKA PHARM CO LTD·Filed 2005·Granted Sep 21, 2010·6 cites·19 claims
- 0475US2026092044A1Pyrimidine derivativeASKA PHARM CO LTD·Filed 2025·Application pending·0 cites
- 0572US8377944B2Thienopyrimidine derivativesASKA PHARM CO LTD·Filed 2012·Granted Feb 19, 2013·2 cites·2 claims
- 0671US12552769B2Pyrimidine derivativeASKA PHARM CO LTD·Filed 2022·Granted Feb 17, 2026·0 cites·5 claims
- 0771US7189412B2Fenofibrate-containing compositionASKA PHARM CO LTD·Filed 2002·Granted Mar 13, 2007·2 cites·4 claims
- 0867US11752102B2Powder preparation for nasal administrationASKA PHARM CO LTD·Filed 2021·Granted Sep 12, 2023·0 cites·7 claims
- 0964US7608716B2Pyrazolonaphthyridine derivativeASKA PHARM CO LTD·Filed 2003·Granted Oct 27, 2009·2 cites·2 claims
- 1063US11234928B2Powder preparation for nasal administrationASKA PHARM CO LTD·Filed 2018·Granted Feb 1, 2022·0 cites·7 claims
- 1163US7449466B2Cyclic aminophenyl sulfamate derivativeASKA PHARM CO LTD·Filed 2004·Granted Nov 11, 2008·2 cites·24 claims
- 1263US2025340557A1Pyrimidine derivativeASKA PHARM CO LTD·Filed 2023·Application pending·0 cites
- 1360US12546788B2Methods for differentiating destructive thyroiditis from other pathological conditionsASKA PHARM CO LTD·Filed 2021·Granted Feb 10, 2026·0 cites·16 claims
- 1460US10508130B2Crystalline polymorph of 15B-hydroxy-osaterone acetateASKA PHARM CO LTD·Filed 2017·Granted Dec 17, 2019·0 cites·9 claims
- 1559US9040536B2Substituted pyrrolo[1,2-a]quinoxalines as PDE9 inhibitorsASKA PHARM CO LTD·Filed 2014·Granted May 26, 2015·0 cites·8 claims
- 1658US9006253B2Crystal of 2-(3,4-dichlorobenzyl)-5-methyl-4-oxo-3,4-dihydrothieno[2,3-D]pyrimidine-6-carboxylic acidASKA PHARM CO LTD·Filed 2014·Granted Apr 14, 2015·0 cites·15 claims
- 1757US12458650B2Urination disorder-improving agentASKA PHARM CO LTD·Filed 2020·Granted Nov 4, 2025·0 cites·7 claims
- 1853US2024041899A1Solid preparationASKA PHARM CO LTD·Filed 2021·Application pending·0 cites
- 1952US2011064844A1Poultry diet for improving textureASKA PHARM CO LTD·Filed 2010·Application pending·0 cites
- 2052US2024425456A1DegraderASKA PHARM CO LTD·Filed 2022·Application pending·0 cites
- 2148US8034801B2Analgesic agentASKA PHARM CO LTD·Filed 2006·Granted Oct 11, 2011·0 cites·5 claims
- 2246US10815268B215-oxosteroid compound and process for producing the sameASKA PHARM CO LTD·Filed 2018·Granted Oct 27, 2020·0 cites·7 claims
- 2346US9643993B2Crystalline polymorphic form of ulipristal acetateASKA PHARM CO LTD·Filed 2013·Granted May 9, 2017·0 cites·10 claims
- 2446US9643994B2Crystalline polymorphic form of ulipristal acetateASKA PHARM CO LTD·Filed 2013·Granted May 9, 2017·0 cites·7 claims
- 2546US2010113484A1Treating agent of uropathyASKA PHARM CO LTD·Filed 2007·Application pending·0 cites
- 2641US2009192164A1Treating agent of inflammatory bowel diseaseASKA PHARM CO LTD·Filed 2007·Application pending·0 cites
- 2739US7939536B2Pyrimidinylisoxazole derivativesASKA PHARM CO LTD·Filed 2005·Granted May 10, 2011·0 cites·10 claims
- 2839US7115623B2PDE IV inhibitorsASKA PHARM CO LTD·Filed 2002·Granted Oct 3, 2006·0 cites·13 claims
- 2933US2009318496A1Preparation containing fibrate agent and process for producing the sameASKA PHARM CO LTD·Filed 2006·Application pending·0 cites
- 3030US2013017245A1Solid preparationASKA PHARM CO LTD·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ASKA PHARM CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →